These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25981751)

  • 1. pH-triggered drug release from biodegradable microwells for oral drug delivery.
    Nielsen LH; Nagstrup J; Gordon S; Keller SS; Østergaard J; Rades T; Müllertz A; Boisen A
    Biomed Microdevices; 2015; 17(3):9958. PubMed ID: 25981751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric microcontainers improve oral bioavailability of furosemide.
    Nielsen LH; Melero A; Keller SS; Jacobsen J; Garrigues T; Rades T; Müllertz A; Boisen A
    Int J Pharm; 2016 May; 504(1-2):98-109. PubMed ID: 27033999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of chitosan and polylactic acid based methotrexate intravitreal micro-implants to treat primary intraocular lymphoma: an in vitro study.
    Manna S; Augsburger JJ; Correa ZM; Landero JA; Banerjee RK
    J Biomech Eng; 2014 Feb; 136(2):021018. PubMed ID: 24317155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of in vitro drug release, pH change, and molecular weight degradation of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) fibers.
    Crow BB; Borneman AF; Hawkins DL; Smith GM; Nelson KD
    Tissue Eng; 2005; 11(7-8):1077-84. PubMed ID: 16144443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fabrication, characterization and drug release characteristics of drug loaded poly (L-lactic acid) fiber].
    Gao H; Ping Q; Gu Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):870-3. PubMed ID: 18788299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilisation of amorphous furosemide increases the oral drug bioavailability in rats.
    Nielsen LH; Rades T; Müllertz A
    Int J Pharm; 2015 Jul; 490(1-2):334-40. PubMed ID: 26026252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of a Single Experimental Design for the Optimization of Furosemide Modified-Release Tablet Formulations.
    Vlachou M; Siamidi A; Dotsikas Y
    Curr Drug Deliv; 2019; 16(10):931-939. PubMed ID: 31663479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards developing surface eroding poly(alpha-hydroxy acids).
    Xu XJ; Sy JC; Prasad Shastri V
    Biomaterials; 2006 May; 27(15):3021-30. PubMed ID: 16455136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring release of ketoprofen enantiomers from biodegradable poly(D,L-lactide-co-glycolide) injectable implants.
    Wang SH; Liang ZH; Zeng S
    Int J Pharm; 2007 Jun; 337(1-2):102-8. PubMed ID: 17296274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of biodegradable liquid core PLLA microcapsules and hollow PLLA microcapsules using microfluidics.
    Lensen D; van Breukelen K; Vriezema DM; van Hest JC
    Macromol Biosci; 2010 May; 10(5):475-80. PubMed ID: 20336699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-pulse drug delivery from a resorbable polymeric microchip device.
    Richards Grayson AC; Choi IS; Tyler BM; Wang PP; Brem H; Cima MJ; Langer R
    Nat Mater; 2003 Nov; 2(11):767-72. PubMed ID: 14619935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of hydrophilic drug from biodegradable polymer blends.
    Tan LP; Hidayat A; Lao LL; Quah LF
    J Biomater Sci Polym Ed; 2009; 20(10):1381-92. PubMed ID: 19622278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced biocompatibility and wound healing properties of biodegradable polymer-modified allyl 2-cyanoacrylate tissue adhesive.
    Lee YJ; Son HS; Jung GB; Kim JH; Choi S; Lee GJ; Park HK
    Mater Sci Eng C Mater Biol Appl; 2015 Jun; 51():43-50. PubMed ID: 25842106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery: pulsed polymers.
    West JL
    Nat Mater; 2003 Nov; 2(11):709-10. PubMed ID: 14593392
    [No Abstract]   [Full Text] [Related]  

  • 15. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
    Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
    Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of different polymers and drug loads for fused deposition modeling of drug loaded implants.
    Kempin W; Franz C; Koster LC; Schneider F; Bogdahn M; Weitschies W; Seidlitz A
    Eur J Pharm Biopharm; 2017 Jun; 115():84-93. PubMed ID: 28232106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin release from poly(D,L-lactic acid) spray-coated hydroxyapatite fibers.
    Ravelingien M; Mullens S; Luyten J; D'Hondt M; Boonen J; De Spiegeleer B; Coenye T; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2010 Nov; 76(3):366-70. PubMed ID: 20816957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the diffusion-controlled release of papaverine from poly (L-lactic acid) matrix.
    Miyajima M; Koshika A; Okada J; Kusai A; Ikeda M
    J Control Release; 1998 Dec; 56(1-3):85-94. PubMed ID: 9801432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabrication of multi-layered biodegradable drug delivery device based on micro-structuring of PLGA polymers.
    Ryu WH; Vyakarnam M; Greco RS; Prinz FB; Fasching RJ
    Biomed Microdevices; 2007 Dec; 9(6):845-53. PubMed ID: 17577671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biorelevant characterisation of amorphous furosemide salt exhibits conversion to a furosemide hydrate during dissolution.
    Nielsen LH; Gordon S; Pajander JP; Østergaard J; Rades T; Müllertz A
    Int J Pharm; 2013 Nov; 457(1):14-24. PubMed ID: 24050989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.